SEC Form 4 · accession 0001513162-16-001082
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Catelani
Officer — Chief Financial Officer
Period of report
Nov 15, 2016
Accepted (ET)
Nov 17, 2016 · 3:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1,F2 | $4.85 | Nov 15, 2016 | A | 50,000 | A | — | Nov 15, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.
- F2The option vest one third on November 15, 2017 and two thirds vest quarterly over two years commencing November 15, 2017.